Thursday December 14th 2017

‘MS in the News’ Archives

Queensland doctors find therapy to halt progression of M.S.

Queensland doctors find therapy to halt progression of M.S.

BRISBANE researchers believe they have found a way to halt the progression of multiple sclerosis. The world-first experimental therapy has already been tried on wheelchair-bound Queensland dad Gary Allen, who has had “big improvements” since receiving the [Read More]

Biogen multiple sclerosis drug Tecfidera wins European approval

Biogen multiple sclerosis drug Tecfidera wins European approval

Biogen Idec Inc’s high profile new multiple sclerosis drug Tecfidera won European approval, the company said on Monday, opening the door for its launch in one of the world’s largest markets for MS treatments. The approval was widely expected after the European [Read More]

Going abroad for Lemtrada for MS is reminiscent of CCSVI

Going abroad for Lemtrada for MS is reminiscent of CCSVI

There are many who suffer from multiple sclerosis (MS) in the United States who are upset with the FDA for not approving of the drug Alemtuzumab, otherwise known as Lemtrada. To the point where a petition was made to fight the ruling. This, on top of Genzyme appealing the [Read More]

 Page 1 of 4  1  2  3  4 »

Latest Topics

Germany’s Merck to make new bid to enter U.S. MS pill market

Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis

Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches

Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

(Natural News) Parkinson’s disease is the second most common neurodegenerative disease plaguing people today, with an [Read More]

Important Research Progress in 2017: Stopping MS, Restoring What’s Been Lost, and Ending MS Forever

Important Research Progress in 2017: Stopping MS, Restoring What’s Been Lost, and Ending MS Forever

/About-the-Society/News/Important-Research-Progress-in-2017-Stopping-MS, [Read More]